Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Mode of action and clinical studies with alemtuzumab.
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.
Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
Deep brain stimulation for other tremors, myoclonus, and chorea.
Education attenuates the negative impact of traumatic brain injury on cognitive status.
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
A machine learning pipeline for multiple sclerosis course detection from clinical scales and patient reported outcomes.
Autoimmune disease: A role for new anti-viral therapies?
The impact of slower walking speed on activities of daily living in patients with multiple sclerosis.
Simvastatin Treatment of Patients With Acute Optic Neuritis
The activities and participation categories of the ICF Core Sets for multiple sclerosis from the patient perspective.
A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity.
Modeling the Relationship among Gray Matter Atrophy, Abnormalities in Connecting White Matter, and Cognitive Performance in Early Multiple Sclerosis.
Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
The most fulminant course of the Marburg variant of multiple sclerosis-autopsy findings.
Aquaporin water channels in the nervous system.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation.
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the extracellular olfactomedin domain of gliomedin.
The mechanism of effective electroacupuncture on T cell response in rats with experimental autoimmune encephalomyelitis.
Induction and molecular signature of pathogenic T(H)17 cells.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
Pages
« first
‹ previous
…
336
337
338
339
340
341
342
343
344
…
next ›
last »